Turning to our FDA pathway. We are very pleased to share that the last patient ... opportunity in the United States that has been created by the availability of GLP-1 drugs. In addition to the data we ...

Oral GLP-1 RA peptide program clinical trial initiated Metsera has ... and multiple potential first-in-class oral follow-on candidates targeting other NuSH pathways, to be developed alone and/or in ...